Scientists Identify Protein That May Limit CAR T-Cell Cancer Therapy Effectiveness
Researchers have identified a protein called NFIL3 that causes CAR T-cells to become exhausted and lose their cancer-fighting ability over time. CAR T-cell therapy is a form of immunotherapy where a patient's immune cells are engineered to target cancer, but its long-term effectiveness has been limited by cell exhaustion. Disabling NFIL3 in animal models allowed the engineered cells to remain potent longer and control tumors more effectively, potentially pointing toward a way to improve the therapy.
A newly identified protein, NFIL3, has been found to play a significant role in the exhaustion of CAR T-cells, which are engineered immune cells used to fight cancer. CAR T-cell therapy has shown promise, particularly in blood cancers, but a persistent challenge has been that the engineered cells lose their effectiveness over time. Researchers discovered that when NFIL3 was disabled in experimental models, the CAR T-cells maintained their strength and tumor-fighting capacity for longer periods. The findings were demonstrated in animal models, meaning further research and clinical trials would be needed before any human applications could be developed. If the results translate to human therapies, targeting NFIL3 could represent a meaningful advance in making CAR T-cell treatments more durable and effective for cancer patients.
What's missing
The article does not specify which types of cancer or which research institution conducted the study, nor does it clarify whether the findings have been peer-reviewed or published in a scientific journal, which is important for assessing credibility.
How coverage differed
Only one source was available for this story, Science Daily, which is rated as center-leaning. The reporting appears straightforward and science-focused, with no notable political or ideological framing detected.
What different sources said
- Science DailyCenter
A single protein may be holding back CAR T cancer therapy
Related
U.S. Establishes Ebola Quarantine Center in Kenya Amid Local Protests and Legal Challenges
The United States is constructing a quarantine facility in Nanyuki, Kenya to isolate American citizens exposed to Ebola in Central Africa, sparking protests and a high court lawsuit from Kenyan residents who fear the virus could be introduced to their country. The facility reflects U.S. policy to prevent Ebola cases from entering the United States, though the Kenyan government has approved it as part of a bilateral partnership. Public health experts and local communities debate whether the facility enhances or undermines regional security and public health cooperation.
Study: Four Minutes of Daily Resistance Training Significantly Improves Fitness in Older Adults
A Penn State College of Medicine study published in PLOS One found that just 4 minutes of daily resistance training significantly improved strength in adults 65 and older within 12 weeks. The research suggests that even minimal daily exercise can substantially impact key health factors affecting fall risk, longevity, and independent living. The findings are notable because they demonstrate that meaningful fitness improvements for older adults may require less time commitment than commonly assumed.
Americans with Severe Obesity Receive Fewer Surgical Procedures Despite Rising Need
Researchers from LSU's Pennington Biomedical Research Center found that Americans with the highest levels of obesity are undergoing fewer surgical procedures overall, including common operations like joint replacements and cancer-related surgeries. The study examined trends across multiple surgical categories including hernia, breast, prostate, and colon procedures. This disparity is significant because it suggests potential barriers to necessary medical care for the most severely obese population.